INSIGHTS ON SOLID DOSE MANUFACTURING
-
The Future Of Sustainable Amorphous Dispersion Development
Sustainable amorphous dispersion cuts cost, risk, and timelines by removing solvent waste, simplifying manufacturing, strengthening supply chains, and scaling efficiently to commercialization.
-
Advancing Patient-Centric Drug Delivery For Neurodegenerative Disease With Orally Dissolving Tablets
Pharmaceutical companies must prioritize patient-centric dosage forms to address challenges like dysphagia, enhance medication compliance, and improve therapeutic outcomes.
-
How To Handle Intrinsic Product Powder Particles
Powder filling creates intrinsic particles that interfere with continuous monitoring. Risk‑based strategies must separate product dust from true contamination to meet Annex 1 requirements.
-
Contract Pharma 2026: Mikart On CDMO Collaboration
An overview of a milestone pharmaceutical outsourcing conference focused on CDMO collaboration, tech transfer, and oral solid and liquid dose manufacturing strategies.
-
Zhunan Facility Site VR Tour12/23/2025
Bora’s 36,000-square-meter Zhunan, Taiwan facility delivers flexible, high-quality cGMP oral solid dose manufacturing with access to major markets including North America and the EU.
-
Bridging The Gap Between Product Readiness And Equipment Availability12/15/2025
Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.
-
Optimizing Yield, Purity, And Scalability In A Cost-Effective Manner During Process Development7/23/2026
Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.
-
The Crucial Role Of Cleaning In Effective VPHP Decontamination For Isolators12/27/2024
Effective isolator cleaning is crucial for vapor phase hydrogen peroxide (VPHP) decontamination. Proper tools, techniques, and training ensure sterility, and regulatory compliance.
-
Advances In Oral GLP-1 Analogs For Obesity9/12/2024
Discover how these groundbreaking Oral GLP-1 Analogs therapies are reshaping obesity management and addressing key challenges in formulation and delivery.
SOLID DOSE MANUFACTURING SOLUTIONS
-
Used ACG capsule filler, model AF TLab, speeds from 6000-25000 capsules/hour, 220 volt, CE design, batch# 2522/10/01, serial# 102, built 2020. includes ACG capsule polisher unit, model DP100, batch# DP62/30/21, serial# 2664, built 2020 and ACG empty capsule sorter, model ECS 100, batch# EC60/30/03, serial# 2098, built 2020.
-
A flexible, data‑driven development approach assembles tailored scientific strategies around each molecule, reducing risk, improving manufacturability, and enabling scalable formulation solutions.
-
Ensure the safety of your personnel, products, and patients with contamination control solutions. From compounding isolators to cleaning and disinfection, discover comprehensive solutions for your pharmacy.
-
Integrated global small‑molecule development and manufacturing solutions spanning chemistry, analytics, scale‑up, and commercial API supply, designed to reduce CMC risk and accelerate progress.
-
Used Sensum tablet inspection machine, model SPINE, designed for inspection of complete surface of tablets, including engraving, speeds up to 360,000 tablets/hour for round and oblong plain tablets, 240,000/hour for engraved round tablets, 300,000 tablets/hour for oblong engraved tablets, with stainless steel product hopper and integrated operator HMI, 230 volt, 60 hertz, CE design, serial# 073, built 2017.